Filing Summary
Business Context and Reporting Period
Landcadia Holdings III, Inc. filed a Form 8-K dated May 11, 2021, in connection with its proposed business combination with HMAN Group Holdings Inc. and its subsidiaries, collectively referred to as Hillman. The filing furnished a Hillman press release announcing financial results for the first quarter ended March 27, 2021.
The filing text provided does not include the financial results contained in Exhibit 99.1; therefore, the reporting-period metrics cannot be summarized from the supplied text.
Financial Metrics
- Revenue, profit, cash flow, margins, debt, liquidity, and other operating metrics: the filing text does not provide clear values.
- The referenced Exhibit 99.1 press release may contain the first-quarter financial results, but its contents were not included in the supplied filing text.
Material Changes Versus Prior Period
The filing does not provide numerical comparisons or clearly describe material changes versus the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
- The filing concerns the proposed business combination and related shareholder solicitation and registration materials; it does not provide specific financial guidance.
- Forward-looking statements address expected future performance, anticipated financial impacts of the transaction, satisfaction of closing conditions, and transaction timing.
- Identified risks include disruption to Hillman’s operations, failure to realize anticipated transaction benefits, competition, growth and employee-retention challenges, transaction costs, regulatory changes, economic and competitive conditions, termination of the merger agreement, litigation, failure to obtain shareholder or regulatory approvals, COVID-19 impacts, and failure to maintain Nasdaq listing.
- The transaction remained subject to required approvals and other closing conditions. The filing does not state that the business combination had closed.
- The information furnished under Item 7.01 and Exhibit 99.1 was not deemed filed for purposes of Exchange Act Section 18 and was not incorporated by reference except where expressly specified.
Investor Verification Items
- Obtain and review Exhibit 99.1 for first-quarter revenue, earnings, cash flow, margins, debt, liquidity, and comparable-period data.
- Review the Form S-4 registration statement and definitive proxy statement/prospectus for transaction terms, dilution, financing, closing conditions, and risk factors.
- Verify whether required Landcadia and Hillman shareholder approvals, regulatory approvals, and Nasdaq listing conditions were satisfied.
- Assess the potential effects of COVID-19, integration and transaction costs, leverage, competition, and employee retention on Hillman’s future results.